DIO Corporation
DIO Corporation manufactures and sells dental implants in South Korea and internationally. The company offers UFII implant internal submerged and no-submerged systems, FTN implant external systems, protem implants, and UV active implant systems. It also provides digital dental implant solutions; and dental products and cardiovascular medical devices. The company was formerly known as DSI Co., Ltd… Read more
DIO Corporation (039840) - Net Assets
Latest net assets as of September 2025: ₩194.78 Billion KRW
Based on the latest financial reports, DIO Corporation (039840) has net assets worth ₩194.78 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩332.33 Billion) and total liabilities (₩137.55 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩194.78 Billion |
| % of Total Assets | 58.61% |
| Annual Growth Rate | 11.52% |
| 5-Year Change | 27.28% |
| 10-Year Change | 162.62% |
| Growth Volatility | 27.42 |
DIO Corporation - Net Assets Trend (2011–2024)
This chart illustrates how DIO Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for DIO Corporation (2011–2024)
The table below shows the annual net assets of DIO Corporation from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩204.11 Billion | +4.98% |
| 2023-12-31 | ₩194.43 Billion | +17.22% |
| 2022-12-31 | ₩165.86 Billion | -11.30% |
| 2021-12-31 | ₩187.00 Billion | +16.61% |
| 2020-12-31 | ₩160.36 Billion | +12.60% |
| 2019-12-31 | ₩142.42 Billion | +25.31% |
| 2018-12-31 | ₩113.66 Billion | +2.97% |
| 2017-12-31 | ₩110.37 Billion | +3.38% |
| 2016-12-31 | ₩106.76 Billion | +37.37% |
| 2015-12-31 | ₩77.72 Billion | +95.32% |
| 2014-12-31 | ₩39.79 Billion | +5.00% |
| 2013-12-31 | ₩37.90 Billion | -16.95% |
| 2012-12-31 | ₩45.64 Billion | -7.77% |
| 2011-12-31 | ₩49.48 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to DIO Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 23169.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩77.98 Billion | 38.20% |
| Common Stock | ₩7.94 Billion | 3.89% |
| Other Components | ₩118.19 Billion | 57.91% |
| Total Equity | ₩204.11 Billion | 100.00% |
DIO Corporation Competitors by Market Cap
The table below lists competitors of DIO Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tuan Sing Holdings Limited
STU:TUS
|
$94.85 Million |
|
Power Engineering Consulting JSC 2
VN:TV2
|
$94.87 Million |
|
CROSSJECT SA EO -10
F:74C
|
$94.89 Million |
|
DUG Technology Ltd
AU:DUG
|
$94.90 Million |
|
Antibiotice Ia
RO:ATB
|
$94.81 Million |
|
Elentec Co. Ltd
KQ:054210
|
$94.81 Million |
|
Highlight Tech
TWO:6208
|
$94.80 Million |
|
Indonesian Paradise Property
JK:INPP
|
$94.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DIO Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 194,427,200,580 to 204,113,830,100, a change of 9,686,629,520 (5.0%).
- Net loss of 41,320,154,650 reduced equity.
- Dividend payments of 1,050,000,000 reduced retained earnings.
- Share repurchases of 9,992,998,800 reduced equity.
- Other factors increased equity by 62,049,782,970.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-41.32 Billion | -20.24% |
| Dividends Paid | ₩1.05 Billion | -0.51% |
| Share Repurchases | ₩9.99 Billion | -4.9% |
| Other Changes | ₩62.05 Billion | +30.4% |
| Total Change | ₩- | 4.98% |
Book Value vs Market Value Analysis
This analysis compares DIO Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.12x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.21x to 1.12x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩7181.21 | ₩15840.00 | x |
| 2017-12-31 | ₩7514.63 | ₩15840.00 | x |
| 2018-12-31 | ₩7738.10 | ₩15840.00 | x |
| 2019-12-31 | ₩9524.10 | ₩15840.00 | x |
| 2020-12-31 | ₩10823.89 | ₩15840.00 | x |
| 2021-12-31 | ₩12628.79 | ₩15840.00 | x |
| 2022-12-31 | ₩11250.15 | ₩15840.00 | x |
| 2023-12-31 | ₩13386.16 | ₩15840.00 | x |
| 2024-12-31 | ₩14123.58 | ₩15840.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DIO Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -20.24%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -34.53%
- • Asset Turnover: 0.35x
- • Equity Multiplier: 1.68x
- Recent ROE (-20.24%) is below the historical average (4.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 10.17% | 9.82% | 0.47x | 2.21x | ₩84.22 Million |
| 2014 | -9.08% | -5.86% | 0.52x | 3.00x | ₩-7.59 Billion |
| 2015 | 14.19% | 15.01% | 0.60x | 1.57x | ₩3.25 Billion |
| 2016 | 19.21% | 23.31% | 0.59x | 1.41x | ₩9.84 Billion |
| 2017 | 7.75% | 9.31% | 0.52x | 1.60x | ₩-2.48 Billion |
| 2018 | 4.80% | 5.99% | 0.40x | 1.98x | ₩-5.91 Billion |
| 2019 | 15.26% | 17.09% | 0.47x | 1.92x | ₩7.49 Billion |
| 2020 | 6.95% | 9.29% | 0.37x | 2.00x | ₩-4.88 Billion |
| 2021 | 15.11% | 18.83% | 0.43x | 1.86x | ₩9.56 Billion |
| 2022 | -12.33% | -15.58% | 0.40x | 1.99x | ₩-37.04 Billion |
| 2023 | 1.70% | 2.13% | 0.42x | 1.89x | ₩-16.13 Billion |
| 2024 | -20.24% | -34.53% | 0.35x | 1.68x | ₩-61.73 Billion |
Industry Comparison
This section compares DIO Corporation's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $361,581,225,861
- Average return on equity (ROE) among peers: -95.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DIO Corporation (039840) | ₩194.78 Billion | 10.17% | 0.71x | $94.83 Million |
| Cellumed Co. Ltd (049180) | $5.18 Billion | -719.12% | 11.54x | $32.46 Million |
| SD Biosensor Inc (137310) | $2.20 Trillion | 48.32% | 0.36x | $174.83 Million |
| Dentium (145720) | $291.10 Billion | 19.06% | 0.96x | $192.13 Million |
| M.I.TECH Co.Ltd (179290) | $14.71 Billion | 4.08% | 0.17x | $45.98 Million |
| JETEMA Co. Ltd (216080) | $-5.04 Billion | 0.00% | 0.00x | $148.99 Million |
| Biodyne Co. Ltd. (314930) | $6.58 Billion | -30.82% | 2.54x | $144.24 Million |
| HASS Corp (450330) | $15.15 Billion | 11.85% | 0.93x | $11.51 Million |